Sequence 1: | NP_001990.2 | Gene: | FBN2 / 2201 | HGNCID: | 3604 | Length: | 2912 | Species: | Homo sapiens |
---|---|---|---|---|---|---|---|---|---|
Sequence 2: | XP_002931771.2 | Gene: | fbn2 / 100494368 | XenbaseID: | XB-GENE-494557 | Length: | 2891 | Species: | Xenopus tropicalis |
Alignment Length: | 2920 | Identity: | 2446/2920 - (83%) |
---|---|---|---|
Similarity: | 2675/2920 - (91%) | Gaps: | 53/2920 - (1%) |
- Green bases have known domain annotations that are detailed below.
Human 3 RRRRLCLQLYFLWLGCVVLWAQGTAGQPQPPPPKPPRPQPPPQQVRSATAGSEGGFLAPEYREEG 67
Human 68 AAVASRVRRRGQQDVLRGPNVCGSRFHSYCCPGWKTLPGGNQCIVPICRNSCGDGFCSRPNMCTC 132
Human 133 SSGQISSTCGSKSIQQCSVRCMNGGTCADDHCQCQKGYIGTYCGQPVCENGCQNGGRCIGPNRCA 197
Human 198 CVYGFTGPQCERDYRTGPCFTQVNNQMCQGQLTGIVCTKTLCCATIGRAWGHPCEMCPAQPQPCR 262
Human 263 RGFIPNIRTGACQDVDECQAIPGICQGGNCINTVGSFECRCPAGHKQSETTQKCEDIDECSIIPG 327
Human 328 ICETGECSNTVGSYFCVCPRGYVTSTDGSRCIDQRTGMCFSGLVNGRCAQELPGRMTKMQCCCEP 392
Human 393 GRCWGIGTIPEACPVRGSEEYRRLCMDGLPMGGIPGSAGSRPGGTGGNGFAPSGNGNGYGPGGTG 457
Human 458 FIPIPGGNGFSPGVGGAGVGAGGQGPIIT-GLTILNQTIDICKHHANLCLNGRCIPTVSSYRCEC 521
Human 522 NMGYKQDANGDCIDVDECTSNPCTNGDCVNTPGSYYCKCHAGFQRTPTKQACIDIDECIQNGVLC 586
Human 587 KNGRCVNTDGSFQCICNAGFELTTDGKNCVDHDECTTTNMCLNGMCINEDGSFKCICKPGFVLAP 651
Human 652 NGRYCTDVDECQTPGICMNGHCINSEGSFRCDCPPGLAVGMDGRVCVDTHMRSTCYGGIKKGVCV 716
Human 717 RPFPGAVTKSECCCANPDYGFGEPCQPCPAKNSAEFHGLCSSGVGITVDGRDINECALDPDICAN 781
Human 782 GICENLRGSYRCNCNSGYEPDASGRNCIDIDECLVNRLLCDNGLCRNTPGSYSCTCPPGYVFRTE 846
Human 847 TETCEDINECESNPCVNGACRNNLGSFNCECSPGSKLSSTGLICIDSLKGTCWLNIQDSRCEVNI 911
Human 912 NGATLKSECCATLGAAWGSPCERCELDTACPRGLARIKGVTCEDVNECEVFPGVCPNGRCVNSKG 976
Human 977 SFHCECPEGLTLDGTGRVCLDIRMEQCYLKWDEDECIHPVPGKFRMDACCCAVGAAWGTECEECP 1041
Human 1042 KPGTKEYETLCPRGAGFANRGDVLTGRPFYKDINECKAFPGMCTYGKCRNTIGSFKCRCNSGFAL 1106
Human 1107 DMEERNCTDIDECRISPDLCGSGICVNTPGSFECECFEGYESGFMMMKNCMDIDECERNPLLCRG 1171
Human 1172 GTCVNTEGSFQCDCPLGHELSPSREDCVDINECSLSDNLCRNGKCVNMIGTYQCSCNPGYQATPD 1236
Human 1237 RQGCTDIDECMIMNGGCDTQCTNSEGSYECSCSEGYALMPDGRSCADIDECENNPDICDGGQCTN 1301
Human 1302 IPGEYRCLCYDGFMASMDMKTCIDVNECDLNSNICMFGECENTKGSFICHCQLGYSVKKGTTGCT 1366
Human 1367 DVDECEIGAHNCDMHASCLNIPGSFKCSCREGWIGNGIKCIDLDECSNGTHQCSINAQCVNTPGS 1431
Human 1432 YRCACSEGFTGDGFTCSDVDECAENINLCENGQCLNVPGAYRCECEMGFTPASDSRSCQDIDECS 1496
Human 1497 FQNICVFGTCNNLPGMFHCICDDGYELDRTGGNCTDIDECADPINCVNGLCVNTPGRYECNCPPD 1561
Human 1562 FQLNPTGVGCVDNRVGNCYLKFGPRGDGSLSCNTEIGVGVSRSSCCCSLGKAWGNPCETCPPVNS 1626
Human 1627 TEYYTLCPGGEGFRPNPITIILEDIDECQELPGLCQGGNCINTFGSFQCECPQGYYLSEDTRICE 1691
Human 1692 DIDECFAHPGVCGPGTCYNTLGNYTCICPPEYMQVNGGHNCMDMRKSFCYRSYNGTTCENELPFN 1756
Human 1757 VTKRMCCCTYNVGKAWNKPCEPCPTPGTADFKTICGNIPGFTFDIHTGKAVDIDECKEIPGICAN 1821
Human 1822 GVCINQIGSFRCECPTGFSYNDLLLVCEDIDECSNGDNLCQRNADCINSPGSYRCECAAGFKLSP 1886
Human 1887 NGACVDRNECLEIPNVCSHGLCVDLQGSYQCICHNGFKASQDQTMCMDVDECERHPCGNGTCKNT 1951
Human 1952 VGSYNCLCYPGFELTHNNDCLDIDECSSFFGQVCRNGRCFNEIGSFKCLCNEGYELTPDGKNCID 2016
Human 2017 TNECVALPGSCSPGTCQNLEGSFRCICPPGYEVKSENCIDINECDEDPNICLFGSCTNTPGGFQC 2081
Human 2082 LCPPGFVLSDNGRRCFDTRQSFCFTNFENGKCSVPKAFNTTKAKCCCSKMPGEGWGDPCELCPKD 2146
Human 2147 DEVAFQDLCPYGHGTVPSLHDTREDVNECLESPGICSNGQCINTDGSFRCECPMGYNLDYTGVRC 2211
Human 2212 VDTDECSIGNPCGNGTCTNVIGSFECNCNEGFEPGPMMNCEDINECAQNPLLCAFRCMNTFGSYE 2276
Human 2277 CTCPIGYALREDQKMCKDLDECAEGLHDCESRGMMCKNLIGTFMCICPPGMARRPDGEGCVDENE 2341
Human 2342 CRTKPGICENGRCVNIIGSYRCECNEGFQSSSSGTECLDNRQGLCFAEVLQTICQMASSSRNLVT 2406
Human 2407 KSECCCDGGRGWGHQCELCPLPGTAQYKKICPHGPGYTTDGRDIDECKVMPNLCTNGQCINTMGS 2471
Human 2472 FRCFCKVGYTTDISGTSCIDLDECSQSPKPCNYICKNTEGSYQCSCPRGYVLQEDGKTCKDLDEC 2536
Human 2537 QTKQHNCQFLCVNTLGGFTCKCPPGFTQHHTACIDNNECGSQPSLCGAKGICQNTPGSFSCECQR 2601
Human 2602 GFSLDATGLNCEDVDECDGNHRCQHGCQNILGGYRCGCPQGYIQHYQWNQCVDENECSNPNACGS 2666
Human 2667 ASCYNTLGSYKCACPSGFSFDQFSSACHDVNECSSSKNPCNYGCSNTEGGYLCGCPPGYYRVGQG 2731
Human 2732 HCVSGMGFNKGQYLSLDTEVDEENALSPEACYECKINGYSKKDSRQKRSIHEPD--------PTA 2788
Human 2789 VE-QISLESVDMDSPVNMKFNLSHLGSKEHILELRPAIQPLNNHIRYVISQGNDDSVFRIHQRNG 2852
Human 2853 LSYLHTAKKKLMPGTYTLEITSIPLYKKKELKKLEESNEDDYLLGELGEALRMRLQIQLY 2912 |
Gene | Sequence | Domain | Region | External ID | Identity |
---|---|---|---|---|---|
FBN2 | NP_001990.2 | Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite | 27..52 | 2/24 (8%) | |
Interaction with MFAP4. /evidence=ECO:0000269|PubMed:26601954 | 149..359 | 188/209 (90%) | |||
TB | 225..258 | CDD:279073 | 31/32 (97%) | ||
EGF_CA | 276..>306 | CDD:214542 | 26/29 (90%) | ||
EGF_CA | 318..358 | CDD:284955 | 30/39 (77%) | ||
TB | 375..412 | CDD:279073 | 26/36 (72%) | ||
EGF_CA | 535..565 | CDD:214542 | 28/29 (97%) | ||
EGF_CA | 575..616 | CDD:214542 | 36/40 (90%) | ||
EGF_CA | 617..649 | CDD:238011 | 30/31 (97%) | ||
cEGF | 638..661 | CDD:289433 | 20/22 (91%) | ||
EGF_CA | 658..698 | CDD:214542 | 35/39 (90%) | ||
TB | 715..751 | CDD:279073 | 32/35 (91%) | ||
cEGF | 790..813 | CDD:289433 | 16/22 (73%) | ||
EGF_CA | 810..845 | CDD:238011 | 33/34 (97%) | ||
TB | 907..>935 | CDD:279073 | 27/27 (100%) | ||
TB | 1012..1047 | CDD:279073 | 31/34 (91%) | ||
EGF_CA | 1115..1149 | CDD:214542 | 30/33 (91%) | ||
EGF_CA | 1158..1190 | CDD:214542 | 26/31 (84%) | ||
EGF_CA | 1200..1232 | CDD:214542 | 28/31 (90%) | ||
cEGF | 1223..1245 | CDD:289433 | 19/21 (90%) | ||
FXa_inhibition | 1246..1281 | CDD:291342 | 30/34 (88%) | ||
Plasmod_Pvs28 | 1293..1446 | CDD:283826 | 128/152 (84%) | ||
EGF_3 | 1371..1406 | CDD:289699 | 26/34 (76%) | ||
EGF_3 | 1412..1447 | CDD:289699 | 24/34 (71%) | ||
EGF_CA | 1532..1563 | CDD:214542 | 28/30 (93%) | ||
TB | 1593..1628 | CDD:279073 | 32/34 (94%) | ||
EGF_CA | 1650..1683 | CDD:238011 | 32/32 (100%) | ||
cEGF | 1672..1695 | CDD:289433 | 21/22 (95%) | ||
Interaction with MFAP4. /evidence=ECO:0000269|PubMed:26601954 | 1735..2171 | 381/435 (88%) | |||
TB | 1749..1786 | CDD:279073 | 32/36 (89%) | ||
EGF_CA | 1808..1840 | CDD:214542 | 30/31 (97%) | ||
vWFA | <1847..1888 | CDD:294047 | 33/40 (83%) | ||
vWFA | <1887..1929 | CDD:294047 | 32/41 (78%) | ||
EGF_CA | 1934..1968 | CDD:214542 | 30/33 (91%) | ||
EGF_CA | 1973..2015 | CDD:214542 | 37/41 (90%) | ||
EGF_CA | 2056..2096 | CDD:214542 | 31/39 (79%) | ||
TB | 2113..2150 | CDD:279073 | 32/36 (89%) | ||
EGF_CA | 2171..2212 | CDD:214542 | 36/40 (90%) | ||
EGF_CA | 2213..2252 | CDD:214542 | 33/38 (87%) | ||
vWFA | <2251..2290 | CDD:294047 | 31/38 (82%) | ||
TB | 2397..2432 | CDD:279073 | 29/34 (85%) | ||
EGF_CA | 2449..2490 | CDD:214542 | 32/40 (80%) | ||
vWFA | <2489..2529 | CDD:294047 | 36/39 (92%) | ||
vWFA | <2527..2563 | CDD:294047 | 33/35 (94%) | ||
EGF_CA | 2614..>2643 | CDD:214542 | 25/28 (89%) | ||
Cadherin_repeat | <2826..>2873 | CDD:206637 | 32/46 (70%) | ||
fbn2 | XP_002931771.2 | EGF_CA | 308..348 | CDD:284955 | 30/39 (77%) |
TB | 365..402 | CDD:279073 | 26/36 (72%) | ||
EGF_CA | 507..537 | CDD:214542 | 28/29 (97%) | ||
EGF_CA | 547..587 | CDD:214542 | 35/39 (90%) | ||
EGF_CA | 589..629 | CDD:214542 | 37/39 (95%) | ||
EGF_CA | 630..670 | CDD:214542 | 35/39 (90%) | ||
TB | 687..723 | CDD:279073 | 32/35 (91%) | ||
EGF_CA | 782..817 | CDD:238011 | 33/34 (97%) | ||
TB | 879..911 | CDD:279073 | 30/31 (97%) | ||
TB | 984..1019 | CDD:279073 | 31/34 (91%) | ||
Plasmod_Pvs28 | 1055..1223 | CDD:283826 | 145/167 (87%) | ||
EGF_CA | 1087..1121 | CDD:214542 | 30/33 (91%) | ||
EGF_CA | 1172..1204 | CDD:214542 | 28/31 (90%) | ||
FXa_inhibition | 1218..1253 | CDD:291342 | 30/34 (88%) | ||
EGF_3 | 1343..1378 | CDD:289699 | 26/34 (76%) | ||
EGF_3 | 1384..1419 | CDD:289699 | 24/34 (71%) | ||
EGF_CA | 1421..1453 | CDD:214542 | 27/31 (87%) | ||
cEGF | 1443..1466 | CDD:289433 | 20/22 (91%) | ||
EGF_CA | 1463..1497 | CDD:238011 | 28/33 (85%) | ||
EGF_CA | 1504..1535 | CDD:214542 | 28/30 (93%) | ||
TB | 1565..1600 | CDD:279073 | 32/34 (94%) | ||
EGF_CA | 1622..1654 | CDD:214542 | 31/31 (100%) | ||
cEGF | 1644..1667 | CDD:289433 | 21/22 (95%) | ||
TB | 1721..1757 | CDD:279073 | 31/35 (89%) | ||
EGF_CA | 1780..1812 | CDD:214542 | 30/31 (97%) | ||
vWFA | <1819..1860 | CDD:294047 | 33/40 (83%) | ||
vWFA | <1855..1901 | CDD:294047 | 35/45 (78%) | ||
EGF_CA | 1906..1940 | CDD:214542 | 30/33 (91%) | ||
vWFA | <1940..1985 | CDD:294047 | 40/44 (91%) | ||
cEGF | 1968..1991 | CDD:289433 | 20/22 (91%) | ||
EGF_CA | 1988..2020 | CDD:214542 | 29/31 (94%) | ||
EGF_CA | 2028..2068 | CDD:214542 | 31/39 (79%) | ||
TB | 2085..2122 | CDD:279073 | 32/36 (89%) | ||
EGF_CA | 2143..2184 | CDD:214542 | 36/40 (90%) | ||
EGF_CA | 2185..2219 | CDD:214542 | 29/33 (88%) | ||
EGF_CA | 2310..2350 | CDD:304395 | 35/39 (90%) | ||
TB | 2369..2404 | CDD:279073 | 29/34 (85%) | ||
EGF_CA | 2421..2454 | CDD:214542 | 26/32 (81%) | ||
vWFA | <2461..2501 | CDD:294047 | 36/39 (92%) | ||
vWFA | <2499..2535 | CDD:294047 | 33/35 (94%) | ||
vWFA | <2541..2577 | CDD:294047 | 26/35 (74%) | ||
cEGF | 2566..2589 | CDD:289433 | 18/22 (82%) | ||
EGF_CA | 2586..>2615 | CDD:214542 | 25/28 (89%) | ||
EGF_CA | 2626..2657 | CDD:214542 | 24/30 (80%) |
Tool | Simple Score | Weighted Score | Original Tool Information | |||
---|---|---|---|---|---|---|
BLAST Result | Score | Score Type | Cluster ID | |||
Compara | 0 | 0.000 | Not matched by this tool. | |||
Domainoid | 1 | 1.000 | 245 | 1.000 | Domainoid score | I12179 |
eggNOG | 0 | 0.000 | Not matched by this tool. | |||
Hieranoid | 0 | 0.000 | Not matched by this tool. | |||
Homologene | 1 | 1.000 | - | - | H1515 | |
Inparanoid | 1 | 1.050 | 5514 | 1.000 | Inparanoid score | I48 |
NCBI | 1 | 1.000 | - | - | ||
OMA | 0 | 0.000 | Not matched by this tool. | |||
OrthoDB | 1 | 1.010 | - | - | D1656at32523 | |
OrthoFinder | 1 | 1.000 | - | - | FOG0005059 | |
OrthoInspector | 1 | 1.000 | - | - | oto156382 | |
Panther | 0 | 0.000 | Not matched by this tool. | |||
Phylome | 0 | 0.000 | Not matched by this tool. | |||
RoundUp | 1 | 1.030 | - | avgDist | Average_Evolutionary_Distance | R17146 |
SonicParanoid | 1 | 1.000 | - | - | X1431 | |
SwiftOrtho | 0 | 0.000 | Not matched by this tool. | |||
TreeFam | 0 | 0.000 | Not matched by this tool. | |||
9 | 9.090 |